RxDoctor Payments DataLook up a doctor →

Jason Wollmuth, MD

Interventional Cardiology · Portland, ORNPI 1164498499

Payments from drug & device makers

$944,764in general payments, 2019–2025

Across 887 payments — averaging $1065.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$514K
  • Abiomed$266K
  • Shockwave Medical, Inc$83K
  • Boston Scientific$53K
  • Philips North America LLC$10K
  • Asahi Intecc USA, Inc.$6K
  • plus $12K from 15 others
$21in research payments, 2019–2025

Across 1 payment — averaging $21.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$21

What the payments were for

  • Consulting fees$394,24553%
  • Speaking & faculty fees$235,00031%
  • Travel & lodging$87,80212%
  • Food & beverage$32,1604%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$944,764 in reported general payments places this provider in the 95th percentile of 68 interventional cardiology providers in Oregon.

See all interventional cardiology providers in Oregon

Medicare billing

Part B allowed, 2024
$133,170
Medicare patients
204
Services billed
637

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan22$22,239
ClopidogrelClopidogrel Bisulfate177$2,120
Atorvastatin Calcium65$812
Metoprolol Succinate31$427
Rosuvastatin Calcium26$393
Isosorbide Mononitrate ErIsosorbide Mononitrate16$290
Losartan Potassium15$163
Amlodipine Besylate25$154
Lisinopril25$132
Carvedilol13$60

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →